Please note that the posting of this information does not constitute Diabetes Canada’s endorsement of the clinical trial, and Diabetes Canada assumes no responsibility for participants’ involvement in or the outcome of the clinical trial.

The aim of this study is to determine whether a combination therapy of insulin and a new drug called exenatide can improve and preserve the function of beta cells of the pancreas in the early course of type 2 diabetes.

The purpose of this study is to determine how many young people with type 1 diabetes in Canada feel that they are or could be treated unfairly because of diabetes; how this relates to health outcomes; and how unfair treatment can be stopped or coped with.